Under construction – not a live service
Sign in
Taking people in FranceNo phase

Irritable Bowel Syndrome Regional Cohort

Key facts

Who runs it
University Hospital, Rouen
Where
Amiens, Caen, Lille, and Rouen, FranceSee the 4 sites
Trial code
Status
Recruiting
People taking part
600 people, planned
Started
4 Mar 2025
Expected to end
4 Sept 2030
Type of study
Observational
Treatments tested
  • self-questionnaires
  • unique collection of saddles
Record updated
8 January 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Patient
  • Normal laboratory work-up as part of routine care (CBC, CRP)
  • Over 18 years of age
  • Patient affiliated to a social security scheme
  • Person who has read and understood the information letter and does not object to taking part in the study

Who cannot take part

  • Patient suffering from an organic digestive pathology (chronic inflammatory bowel disease, microscopic colitis when endoscopy has been performed because deemed necessary, digestive cancer, coeliac disease) or major digestive surgery (excluding appendectomy and cholecystectomy)
  • Patient refusal
  • Patient does not speak or understand French
  • A pregnant woman or a woman in labour or breastfeeding
  • Person deprived of liberty by an administrative or judicial decision or person placed under court protection / sub- guardianship or curatorship

Where in France

  • University Hospitol of AmiensAmiens, FranceContact: Mathurin MF FUMERY, ProfessorNot yet recruiting
  • CHU de CAENCaen, FranceContact: Oumniya OA ARJAFALLAH GOULET, ProfessorNot yet recruiting
  • University Hospital of LilleLille, FranceContact: Pauline PW WILS, DoctorNot yet recruiting
  • University Rouen HospitalRouen, FranceContact: Chloé CM MELCHIOR, ProfessorTaking people

About the trial

What the trial wants to find out

Setting up a regional (multicentre), longitudinal cohort of people suffering from irritable bowel syndrome followed up in consultation to study the natural history of the disease and its prognosis.

The group in the trial

  • Patients with irritable bowel syndrome

    Patients with irritable bowel syndrome according to the Rome criteria in force at the time of inclusion (IV in 2024, V expected in 2025)

    Treatment: self-questionnaires and unique collection of saddles

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Development of a Regional Irritable Bowel Syndrome Cohort
Record updated
8 January 2026